2012 Annual Meeting | Clinical Usefulness of Botulinum Toxin and Treatment of Dystonia
| 12:00 PM - 05:00 PM |
Patient Waiting Room
|
|
| 12:00 PM - 05:00 PM |
Break
|
|
| 01:00 PM - 01:20 PM |
Introduction and Discussion on Practical Differences Between the Four Types of Botulinum Toxin
Vanessa K. Hinson, MD, PhD, FAAN |
|
| 01:20 PM - 05:00 PM |
Patient Demo Rotation 1
Cynthia L. Comella, MD, FAAN |
|
| 01:20 PM - 05:00 PM |
Patient Demo Rotation 2
Marian L. Evatt, MD, FAAN |
|
| 01:20 PM - 05:00 PM |
Patient Demo Rotation 3
Barbara P. Karp, MD, FAAN |
|
| 01:20 PM - 05:00 PM |
Patient Demo Rotation 4
Vanessa K. Hinson, MD, PhD, FAAN |
|
| 03:10 PM - 03:25 PM |
Break
|
| Cynthia L. Comella, MD, FAAN | Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care. |
| Barbara P. Karp, MD, FAAN | Dr. Karp has received personal compensation in the range of $500-$4,999 for serving as a Faculty for a course on chemodenervation with Catalyst Medical 好色先生. |
| Marian L. Evatt, MD, FAAN | No disclosure on file |
| Vanessa K. Hinson, MD, PhD, FAAN | The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories. |